Blue or red pill? Supermedicine, please!

In the Matrix, the choice was between the comfort of illusion and the harsh reality of truth. Today’s healthcare industry faces a similar fork in the road. Do we stay the course with the "Blue Pill", a traditional, reactive system focused on treating illness, or do we take the "Red Pill" and embrace a new era of Supermedicine?

Supermedicine isn't just about futuristic labs; it is the powerful convergence of pharmaceutical breakthroughs like GLP-1s, continuous bio-data from wearables, and the deep-tech infrastructure making personalized health scalable. This shift is moving medicine from the hospital into the pocket and the palm of the consumer.

Join a panel of leaders in the healthcare industry as they discuss the transition from "sick-care" to "performance-care." We will explore:

• The Convergence of Data & Biology: How the marriage of hardware (Garmin) and breakthrough therapeutics (GLP-1s) is creating a 24/7 feedback loop for human health.
• The Investment in Longevity: Why the smartest capital is moving toward preventative, tech-enabled platforms that aim to extend "healthspan" rather than just lifespan.
• The Infrastructure of Optimization: How do we actually build, scale, and consult on the "Supermedicine" products of tomorrow?

17:15 – 17:55 | Panel Discussion

Speakers:

• Javier Nunez-Vicand, Principal - Digital Medicine Strategy, Sofinnova Partners
• Ivana Knyght, Vice President, Capgemini
• Benedikt Kurz, Teamlead Garmin Health EMEA, Garmin
• Moderator: Helena Torras, Managing Partner, Paocapital